SCHEMBL28109347

SCHEMBL28109347

O=C(O)c1ccc(Cc2cccc(F)c2)nc1CBr

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.46
BRS3 P32247 1/20 0.40
GPR52 Q9Y2T5 1/20 0.39
NR4A2 P43354 2/20 0.39
DCLRE1B Q9H816 1/20 0.39
KDM5A P29375 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
SRC P12931 1/20 0.38
HPN P05981 1/20 0.38
SLC1A1 P43005 2/20 0.37
RPS6KB1 P23443 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9938245 0.76 HCAR2 (0.58) HCAR2NR4A2
SCHEMBL28109060 0.75 SRD5A2 (0.47) KDM5AKDM4CKDM5B
SCHEMBL9937529 0.74 HCAR2 (0.51) HCAR2BRS3NR4A2DCLRE1BSLC1A1
SCHEMBL28105342 0.72 HCAR2 (0.52) HCAR2BRS3NR4A2DCLRE1BSLC1A1
SCHEMBL28108996 0.71 GABRP (0.50) LMNA
SCHEMBL1542175 0.70 GABRP (0.53) POLB
SCHEMBL6856480 0.70 HCAR2 (0.54) HCAR2BRS3NR4A2KDM5AKDM4C
SCHEMBL28117926 0.70 TSHR (0.57) HCAR2BRS3NR4A2DCLRE1B
SCHEMBL19662728 0.69 HCAR2 (0.47) HCAR2NR4A2KDM5AKDM4CKDM5B
SCHEMBL4677 0.69 TAAR1 (0.42) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106146491-B The naphthyridine compounds of 5 hydroxyl 1,7, its preparation method and its pharmaceutical applications being optionally substituted aryl or heteroaryl 沈阳三生制药有限责任公司 2017-12-12 CN disclosed
CN-106146491-A 5-hydroxyl-1,7-naphthyridine compounds, its preparation method and the pharmaceutical applications thereof being optionally substituted aryl or heteroaryl 沈阳三生制药有限责任公司 2016-11-23 CN disclosed